Log In
Print
BCIQ
Print
Print this Print this
 

J-HER cancer vaccine

  Manage Alerts
Collapse Summary General Information
Company Cel-Sci Corp.
DescriptionVaccine using Ligand Epitope Antigen Presentation System (L.E.A.P.S.) T cell modulation platform technology to activate tumor-specific killer T cells
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat HER2-positive breast cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today